Beijing Shuanglu Pharmaceutical
4th Floor, Building 1, Bitong Garden, No. 69 Fushi Road, Beijing, Haidian District, 100143, China
Overview
Beijing SL Pharmaceutical is a research and development company that offers new drugs. They provide products that reserves in the fields of blood, tumor treatment, cardiovascular and cerebrovascular treatment, liver disease treatment, diabetes treatment, and kidney disease treatment.
- Total investments
- 1
- Lead investments
- 1
- Investments · 12mo
- 0
- Active investors
- 1
Sector focus
- Health Care
- Manufacturing
- Pharmaceutical
Investment portfolio
- Pro-Heal Pharmaceuticals
Led · Equity · Jun 2024
Pulekang Pharmaceutical develops innovative drugs concentrating on autoimmune diseases and cancer indications. The company emphasizes biologic macromolecule drug development. Recently Pulekang received an investment of RMB 40 million. The round was invested solely by Shuanglu Pharma. The raised funds will be used to support R&D of Pulekang's ophthalmology clinical drug pipeline.
Team
Mingbo Xu
President & Founder & Chief Executive Officer